The healthcare landscape in Michigan is undergoing significant evolution, driven by technological advancements, patient demand for accessible care, and a proactive regulatory environment. For telehealth founders, medspa operators, and practice owners looking to expand into or within the Wolverine State, understanding these intricacies is not merely advisable—it is absolutely essential for compliant and sustainable growth. Michigan's regulatory bodies, particularly the Board of Medicine, have demonstrated a clear intent to scrutinize new care models, making a robust compliance strategy paramount.
For more on this topic, see our analysis: Michigan's Regulatory Crossroads: Navigating Telehealth, Medspas, and CPOM in the Wolverine State.
The Corporate Practice of Medicine (CPOM) in Michigan: A Nuanced Approach
Michigan's stance on the Corporate Practice of Medicine (CPOM) is less overtly strict than some states like Iowa or Kentucky, yet it still requires careful navigation. While there isn't a blanket statutory prohibition against corporations employing physicians, the Michigan Public Health Code (MCL 333.16101 et seq.) and the administrative rules for various health professions boards imply a strong preference for professional independence and control over clinical decision-making. The core principle is that medical judgments should not be influenced by commercial interests or non-licensed entities.
For more on this topic, see our analysis: Michigan's Regulatory Crossroads: Navigating Telehealth, Medspas, and CPOM in the Wolverine State.
For telehealth brands, this means that while a non-professional entity might own the technology platform or provide administrative services, the entity directly employing or contracting with Michigan-licensed physicians, PAs, or NPs for medical services must typically be a professional corporation (PC) or professional limited liability company (PLLC) owned by licensed professionals. Management Service Organization (MSO) models are widely utilized, but they must be meticulously structured. The MSO agreement must clearly delineate administrative services from clinical ones, ensuring the MSO does not control clinical protocols, dictate medical fees, or engage in fee-splitting. Any arrangement where a non-clinical entity profits directly from the provision of medical services without providing fair market value for administrative support can draw scrutiny.
Medspas face particular challenges here. The aesthetic services offered often blend medical and non-medical components. Services requiring a medical license (e.g., injectables, laser treatments, certain chemical peels) must be performed under the direct supervision or delegation of a licensed physician, APRN, or PA operating within a compliant professional structure. The medical director cannot be a mere figurehead; they must be actively engaged and providing appropriate supervision. Non-medical spa services can be offered by a corporate entity, but the medical services must be provided by a separate, professionally owned entity or through a compliant MSO arrangement that respects CPOM principles. Misrepresentation of services or provider qualifications is a significant risk area, as highlighted by recent enforcement trends.
Dental practices and chiropractic offices are also subject to their respective professional practice acts and CPOM principles. While specific statutes may allow for certain corporate structures for these professions, any deviation from traditional professional ownership or attempts by non-licensed entities to control clinical practice could trigger violations. The Michigan Boards of Dentistry and Chiropractic maintain similar expectations regarding professional independence.
Telehealth-Specific Regulations and Recent Changes
Michigan has been proactive in codifying telehealth regulations, moving beyond the temporary flexibilities of the COVID-19 Public Health Emergency (PHE). The state defines telehealth broadly, encompassing synchronous and asynchronous modalities, and generally permits its use for establishing a patient-provider relationship, diagnosis, consultation, and treatment. Key elements include:
- Establishment of Patient-Provider Relationship: Michigan generally allows for the establishment of a patient-provider relationship via telehealth, provided the standard of care is met. This means an appropriate evaluation, including a history and physical examination, must be conducted to establish a diagnosis and treatment plan. The mode of interaction (audio-visual, audio-only) often depends on the specific service and the practitioner's judgment regarding what's necessary to meet the standard of care.
- Consent: Informed consent for telehealth services is mandatory. Patients must be informed of the nature of telehealth, potential risks and benefits, privacy protections, and how to access follow-up care.
- Documentation: All telehealth encounters must be thoroughly documented in the patient's medical record, consistent with in-person care documentation standards.
- Prescribing: Prescribing via telehealth is permitted, but with significant caveats, especially for controlled substances. We will delve into this further below.
- Licensure: Providers must be fully licensed in Michigan to provide telehealth services to patients located in Michigan. There are no interstate compacts for physicians that would allow out-of-state physicians to practice without a Michigan license, though some limited exceptions may exist for specific emergency situations or consultations.
Recent Changes and Trends: The Michigan Board of Medicine has increased its scrutiny of telehealth operations. The "Michigan Medical Board Enforcement Trends" intelligence indicates a heightened focus on ensuring that all practitioners are appropriately licensed, that patient-provider relationships are established in accordance with state law (e.g., proper initial evaluations, informed consent), and that prescribing practices strictly adhere to Michigan's Public Health Code and administrative rules. This signals a move towards stricter enforcement of existing regulations rather than a broad relaxation of rules.
Medical Board Requirements for Telehealth Providers
The Michigan Board of Medicine and other professional boards (e.g., Nursing, Osteopathic Medicine, Pharmacy) expect telehealth providers to adhere to the same standards of care as in-person care. This includes:
- Licensure: As noted, full Michigan licensure is required.
- Standard of Care: Telehealth services must meet the generally accepted standard of care. If a provider determines that an in-person examination is necessary to meet this standard, they must advise the patient and facilitate such an examination.
- Patient Identification: Robust processes for verifying patient identity and location are crucial.
- Privacy and Security: HIPAA-compliant platforms and practices are non-negotiable.
- Emergency Protocols: Providers must have clear protocols for handling medical emergencies during or after a telehealth encounter, including referral to local emergency services if needed.
Collaborative Practice and Supervision Requirements
Michigan has specific requirements for collaborative practice and supervision, particularly for Physician Assistants (PAs) and Nurse Practitioners (NPs), which are critical for medspas and other team-based care models.
- Physician Assistants (PAs): PAs in Michigan must practice under the supervision of a licensed physician. The scope of practice for a PA is determined by the supervising physician's scope of practice and the PA's education, training, and experience. A written delegation of services agreement (DSA) is required, outlining the specific acts and services the PA is authorized to perform. Supervision can be indirect, but the supervising physician must be available for consultation and review of patient charts. For medspas, this means the supervising physician must be genuinely engaged and oversee the PA's activities, not just lend their name.
- Nurse Practitioners (NPs) / Advanced Practice Registered Nurses (APRNs): Michigan's Public Health Code (MCL 333.17210) defines the scope of practice for NPs. While NPs can diagnose, treat, and prescribe, they generally operate under a collaborative practice agreement with a physician, especially for complex cases or initial prescriptive authority. The specifics of supervision and collaboration can vary, but the emphasis is on ensuring appropriate oversight and patient safety. For medspas, if an NP is performing medical aesthetic procedures, the collaborative agreement must clearly define the scope and supervision model, ensuring the NP operates within their legal and professional boundaries.
Inadequate supervision is a frequent trigger for enforcement actions, particularly in medspa settings. Businesses must ensure that medical directors are actively engaged and providing direct, on-site supervision as required, and that all procedures are performed by licensed professionals within their scope.
Controlled Substance Prescribing Rules
Prescribing controlled substances via telehealth in Michigan is highly regulated, aligning with federal DEA requirements and state-specific rules. The landscape has been significantly impacted by the expiration of COVID-19 PHE waivers and the DEA's proposed rules.
- Ryan Haight Act and In-Person Exam: Federally, the Ryan Haight Act generally requires an in-person medical evaluation before prescribing controlled substances via telemedicine. While COVID-19 PHE waivers temporarily lifted this, the DEA has proposed rules that would largely reinstate this requirement, with specific exceptions for buprenorphine for OUD under certain conditions. The temporary extension of PHE flexibilities until November 2024 for established patient-prescriber relationships provides a brief reprieve but underscores the eventual return to stricter requirements.
- Michigan's Public Health Code: Michigan's Public Health Code and administrative rules (e.g., Michigan Administrative Code R 338.3101 et seq.) govern controlled substance prescribing. These rules emphasize the need for a legitimate medical purpose, a bona fide patient-prescriber relationship, and thorough documentation. Providers must perform an adequate assessment to justify the prescription, which for controlled substances, often implies an in-person component unless explicitly waived or deemed appropriate via robust telehealth evaluation.
- MAPS (Michigan Automated Prescription System): Michigan mandates the use of MAPS, the state's prescription drug monitoring program (PDMP), before prescribing or dispensing Schedule 2-5 controlled substances. Providers must query MAPS to review a patient's controlled substance history to identify potential drug-seeking behavior or over-prescribing.
- Buprenorphine for OUD: While the DEA's proposed rules offer some flexibility for buprenorphine, Michigan providers must still adhere to state-specific requirements for treating opioid use disorder, including specific training and registration requirements.
For telehealth providers, this means a hybrid model, combining virtual consultations with in-person assessments, will likely become the standard for controlled substance prescriptions. Robust protocols to document in-person evaluations, track patient-prescriber relationships established during the PHE, and ensure proper record-keeping are essential. The DOJ's intensified enforcement against telehealth controlled substance prescribing violations further underscores the critical importance of strict adherence to these rules.
State-Specific Licensing and Registration Requirements
Operating in Michigan requires meticulous attention to licensing and registration:
- Professional Licensure: All healthcare professionals (physicians, PAs, NPs, RNs, dentists, chiropractors, etc.) must hold a current, unrestricted license issued by their respective Michigan professional board. This includes any provider offering telehealth services to Michigan residents.
- Facility Licensing: Certain types of healthcare facilities (e.g., hospitals, ambulatory surgical centers, freestanding surgical outpatient facilities) require specific state licensing. While most telehealth-only operations may not fall under these, physical locations for medspas or hybrid clinics might.
- DEA Registration: Providers prescribing controlled substances must have a valid DEA registration. If prescribing to patients in Michigan, they must have a DEA registration associated with a Michigan address.
- Business Registration: Any business entity (e.g., LLC, corporation) operating in Michigan must be registered with the Michigan Department of Licensing and Regulatory Affairs (LARA).
Recent Enforcement Actions or Notable Cases
The Michigan Board of Medicine and other professional boards have been increasingly active. While specific named cases are often confidential until disciplinary action is finalized, the "Michigan Medical Board Enforcement Trends" intelligence clearly indicates a focus on:
- Unprofessional Conduct: Broadly defined, this can include inadequate patient care, improper prescribing, or failure to maintain appropriate records.
- Scope of Practice Violations: Particularly prevalent in medspas where non-physicians may perform procedures outside their authorized scope, or where supervision is insufficient.
- Inadequate Supervision: As discussed, this is a significant risk area for PAs and NPs, especially in medspa or other delegated practice settings.
- Telehealth Non-Compliance: Actions stemming from improper establishment of patient-provider relationships, failure to meet the standard of care via telehealth, or improper prescribing via telehealth.
These trends suggest that the Board is actively monitoring and enforcing regulations, with disciplinary actions often leading to license suspension, revocation, or significant fines. The DOJ's broader focus on telehealth controlled substance fraud also means Michigan-based providers are subject to federal scrutiny.
Key Compliance Pitfalls and How to Avoid Them
- Ignoring CPOM Nuances: Assuming Michigan is a "friendly" CPOM state can be a costly mistake. Structure your entity as a professional corporation or PLLC for clinical services, and ensure MSO agreements are strictly administrative, at fair market value, and do not influence clinical decisions. Action: Engage Michigan-specific legal counsel to review your corporate structure and MSO agreements.
- "Paper" Medical Directors: In medspas or delegated practice models, a medical director who is not actively engaged or providing adequate supervision is a significant liability. Action: Ensure your medical director is genuinely involved, understands their responsibilities, and provides documented oversight and training.
- Telehealth Prescribing Missteps: Assuming all prescribing via telehealth is permissible, especially for controlled substances, is a major pitfall. Action: Implement rigorous protocols for patient evaluation, documentation, and MAPS checks for all controlled substances. Prepare for a future where in-person evaluations may be required for initial controlled substance prescriptions.
- Licensure Lapses: Providing care to Michigan residents without proper Michigan licensure is a direct violation. Action: Implement a robust credentialing system to verify and track all provider licenses and DEA registrations.
- Inadequate Documentation: Poor or incomplete documentation of telehealth encounters, patient consent, and supervision can be fatal during an audit or investigation. Action: Standardize documentation practices to meet or exceed in-person care standards, including clear records of informed consent for telehealth.
- Failure to Monitor Regulatory Changes: The regulatory environment is dynamic. What was compliant yesterday may not be today. Action: Subscribe to alerts from Michigan's LARA, Board of Medicine, and other relevant professional boards. Conduct regular internal compliance audits.
Comparison with Neighboring States
Michigan's regulatory approach shares similarities and differences with its neighbors:
- Ohio: Ohio also has a CPOM doctrine that is generally recognized, requiring careful structuring of medical practices. Ohio has been similarly active in defining telehealth rules, including specific requirements for establishing a patient-provider relationship and prescribing controlled substances, often mirroring federal guidelines.
- Indiana: Indiana generally has a less strict CPOM enforcement history, with more flexibility for corporate ownership, although professional independence is still valued. Telehealth regulations are evolving, with a focus on parity and appropriate use.
- Wisconsin: Wisconsin's CPOM is also less restrictive than some other states, often allowing for corporate employment of physicians under certain conditions. Telehealth regulations are well-established, emphasizing the standard of care and licensure.
While each state has its nuances, Michigan's emphasis on active medical board oversight, particularly in emerging areas like telehealth and medspas, positions it as a state where proactive compliance is critical. Its CPOM interpretation, while not the strictest, still demands thoughtful legal structuring to avoid issues.
What This Means For Your Practice
Operating or expanding a healthcare business in Michigan requires a comprehensive understanding of its regulatory framework. For telehealth brands, this means investing in technology that supports Michigan's requirements for patient-provider relationship establishment and ensuring all providers are properly licensed. For medspa operators, it necessitates rigorous adherence to scope of practice, robust medical director oversight, and a compliant corporate structure that respects CPOM. Dental and chiropractic practices must ensure any telehealth offerings or adjunctive services remain strictly within their professional scope and adhere to supervision requirements.
TrueEval's Perspective: The Michigan Board of Medicine's increased scrutiny signals a critical need for robust compliance frameworks within these sectors. Proactive internal audits, comprehensive staff training on compliance, and clear documentation of patient care, supervision, and informed consent are not merely best practices—they are essential safeguards. Ignorance of the law is not a defense, and the Board's disciplinary actions serve as a reminder that regulatory compliance is an ongoing, critical responsibility. Engage experienced legal counsel with Michigan-specific expertise to review your operations and ensure your compliance strategy is ironclad. This proactive approach will not only mitigate risks but also position your practice for sustainable success in Michigan's evolving healthcare market.
Further Reading
- Michigan's Regulatory Crossroads: Navigating Telehealth, Medspas, and CPOM in the Wolverine State
- Michigan's Evolving Healthcare Landscape: Navigating Telehealth, Medspa, and CPOM Compliance
- Michigan's Regulatory Crossroads: Navigating Telehealth, Medspas, and the Board's Intensified Scrutiny
- The Looming Convergence: How Telehealth and Brick-and-Mortar Care Are Merging, and What It Means for Your Strategy


